Marvel Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:MBCO.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
12 Nov 25	BuyUS$786	J. Matheson	Individual	5,500	US$0.14
14 Oct 25	BuyUS$8,197	J. Matheson	Individual	49,000	US$0.17
28 Aug 25	BuyUS$5,196	J. Matheson	Individual	30,000	US$0.17
15 Aug 25	BuyUS$5,046	Renaissance Mercantile Corp	Company	35,000	US$0.14
13 Aug 25	BuyUS$1,380	J. Matheson	Individual	10,000	US$0.14
12 Aug 25	BuyUS$8,258	J. Matheson	Individual	60,000	US$0.14
08 Aug 25	BuyUS$6,637	J. Matheson	Individual	50,000	US$0.13
06 Aug 25	BuyUS$3,093	J. Matheson	Individual	25,000	US$0.12
01 Aug 25	BuyUS$6,192	J. Matheson	Individual	49,000	US$0.13
30 Jul 25	BuyUS$4,030	J. Matheson	Individual	35,000	US$0.12
29 Jul 25	BuyUS$697	J. Matheson	Individual	6,000	US$0.12
16 Jul 25	BuyUS$1,351	J. Matheson	Individual	10,000	US$0.14
15 Jul 25	BuyUS$2,769	J. Matheson	Individual	20,000	US$0.14
09 Jul 25	BuyUS$6,824	J. Matheson	Individual	55,000	US$0.12
04 Jul 25	BuyUS$3,123	J. Matheson	Individual	25,000	US$0.12
30 Jun 25	BuyUS$1,210	J. Matheson	Individual	10,000	US$0.12
20 Jun 25	BuyUS$17,416	J. Matheson	Individual	184,000	US$0.095
12 Jun 25	BuyUS$4,039	J. Matheson	Individual	50,000	US$0.081
05 Jun 25	BuyUS$4,231	J. Matheson	Individual	55,000	US$0.077
29 May 25	BuyUS$3,043	J. Matheson	Individual	40,000	US$0.076
13 May 25	BuyUS$4,670	J. Matheson	Individual	75,000	US$0.062
08 Apr 25	BuyUS$21,097	Virtus Advisory Group Inc.	Company	240,000	US$0.088
08 Apr 25	BuyUS$7,032	Neil Johnson	Individual	80,000	US$0.088
08 Apr 25	BuyUS$17,581	Abingdon Capital Corporation	Company	200,000	US$0.088
08 Apr 25	BuyUS$28,394	The Royal Borough of Kensington and Chelsea	Company	323,000	US$0.088
21 Feb 25	BuyUS$3,449	J. Matheson	Individual	35,000	US$0.099

Insider Trading Volume

Insider Buying: MBCO.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MBCO.F?
Owner Type	Number of Shares	Ownership Percentage
State or Government	323,000	0.557%
Private Companies	530,000	0.914%
Institutions	5,527,500	9.53%
Individual Insiders	8,066,598	13.9%
General Public	43,557,383	75.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.5%.

Top Shareholders

Top 9 shareholders own 24.91% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.07%	Renaissance Mercantile Corp	5,259,000	US$537.5k	0%	no data
8.62%	Mark Williams	5,000,049	US$511.1k	0%	no data
3.53%	J. Matheson	2,046,549	US$209.2k	2.74%	no data
1.11%	Jacqueline Groot	645,000	US$65.9k	0%	no data
0.91%	Abingdon Capital Corporation	530,000	US$54.2k	0%	no data
0.56%	The Royal Borough of Kensington and Chelsea	323,000	US$33.0k	0%	no data
0.46%	Virtus Advisory Group Inc.	268,500	US$27.4k	0%	no data
0.35%	Neil Johnson	205,000	US$21.0k	0%	no data
0.29%	Babak Pedram	170,000	US$17.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/01/25 07:00
End of Day Share Price	2026/01/23 00:00
Earnings	2025/10/31
Annual Earnings	2025/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Marvel Biosciences Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.